Several personal and treatment-related factors affect the duration and impact of IV therapy: Your metabolism and body composition Nutrient deficiencies or health conditions Lifestyle habits (diet, alcohol, exercise, stress) The formulation and dosage of the IV blend Frequency of treatments Factors Affecting Retention: The length of time IV therapy benefits last varies based on hydration status, metabolism, age, stress levels, and overall health
This ensures you receive the safest, most effective treatment
Metabolic levels associated with MTX resistance In addition to the association between metabolic fold change and MTX resistance, we searched for correlations between metabolic concentration and resistance to MTX (expressed as IC50) at 48 and 96 hours in either the presence or absence of the drug ( Table 1 )
Where can I read the original time-course studies
In spinal cord injury, the expression of the ubiquitin protein ligase E3 component N-recognin 1 (UBR1) is diminished due to METTL14-mediated RNA modifications, which subsequently increases the levels of BAX/BAK protein [249]